CDSCO Issues Clarification On Registration Certificate Issuance Under Cosmetics Rules 2020 (12-08-2021)

New Delhi : The Central Drugs Standard Control Organization (CDSCO) has clarified that those who want to apply for the Registration Certificate for their existing cosmetic products under the new Cosmetics Rules 2020, may need to submit a “no change declaration statement.”

The clarification comes in the backdrop of the regulator receiving various concerns and reports of challenges from the stakeholders after the implementation of the separate rule, which was notified on December 15, 2020.

“On commencement of these new cosmetic rules, this office has received various concerns and challenges faced by the stakeholders regarding application for grant of import registration certificates and subsequent endorsements,” said the notice issued by Dr V G Somani, Drugs Controller General (India) on August 6, 2021.

The validity of product endorsement granted under the existing RC in Form 43 as per the Drugs and Cosmetics Rules, 1945, will be effective from its date of issuance till the validity of parent RC in Form 43. Currently option for endorsement in Form 43, the old RC, has been disabled for streamlining the process of implementation of Cosmetic Rules 2020 and further IT issues as informed by the CDAC Team.

“No Change Declaration Statement” with respect to composition, product label, specifications and test methods is required to be submitted for issuance of Registration Certificate or endorsement in Form COS-2 for products which are already registered in Form 43 in the erstwhile provisions of Drugs and Cosmetics Rules, 1945. Further, an authorisation from manufacturer in specified format, information as per second schedule (Part 1) of the Rules and requisite fees for category, manufacturing sites and variants, as applicable is required to be submitted, added the CDSCO.

For additional pack size endorsements for already registered cosmetics products, the same No change declaration statement has to be submitted along with other details as mentioned for the issuance of the RC. For additional manufacturing site endorsement for already registered cosmetics products too, these documents need to be submitted.

The CDSCO also added that it is already processing the product/additional pack size/additional site endorsement applications for previously registered products having valid RC under Rule 72 of Cosmetics Rules, 2020 on the basis of the documents mentioned already.

The regulator has earlier also issued FAQs for the cosmetics manufacturers and importers, in order to alleviate their doubts that emerged in the wake of the implementation of the new rules. The new clarification comes as the latest in these FAQs, it added.

  • Related Posts

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal Pharma Solutions, a global contract development and manufacturing organization, and Ajinomoto Bio-Pharma Services announced a strategic collaboration to support development and manufacturing of antibody-drug conjugates (ADCs) using AJICAP technology…

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    New Delhi: Aurobindo Pharma Ltd on Friday said it has received final approval from the US health regulator to manufacture and market its generic version of glycerol phenylbutyrate oral liquid…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal, Ajinomoto team on ADC development and manufacturing

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Cancer cure must not be hostage to Big Pharma

    Cancer cure must not be hostage to Big Pharma

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India